...
首页> 外文期刊>Clinical and experimental allergy : >Suppression of the late asthmatic reaction by hyposensitization in asthmatic children allergic to house dust mite (Dermatophagoides pteronyssinus)
【24h】

Suppression of the late asthmatic reaction by hyposensitization in asthmatic children allergic to house dust mite (Dermatophagoides pteronyssinus)

机译:通过对室内尘螨(Dermatophagoides pteronyssinus)过敏的哮喘儿童的脱敏抑制晚期哮喘反应

获取原文

摘要

SummaryIn this study, we wanted to test the hypothesis that hyposensitization (HS) abrogates the late asthmatic reaction (LAR). We therefore selected 15 asthmatic children (subjects) sensitized to house dust mite (HDM), as proven by positive prick tests and/or specific IgE via the RAST. All children demonstrated a positive bronchial provocation test (BPT) to HDM; 14 showed a dual asthmatic reaction and one child showed an isolated LAR. All children were treated with anti‐asthmatic drugs and received HS. They were rechallenged after 1 yr of HS while their anti‐asthmatic medication was not changed, except for β‐agonists which were used only for relief of symptoms. Two BPTs, with a mean interval of 6.4 months, were also performed in eight asthmatic children (controls), who did not receive HS. In the controls, the same reaction pattern was observed during both BPTs. In the subjects, the LAR completely resolved in 5/15 after 1 yr of HS (P= 0.04). Furthermore, as a group, the subjects showed a less severe LAR after 1 yr of HS (expressed as mean fall of FEV1) (P<0.0001). The PD20of the immediate asthmatic reaction (IAR) was the same as before HS was started, but the IAR was also less severe after 1 yr of HS (expressed as mean fall of FEV1) (P= 0.028). From these observations it is concluded that, in asthmatic children, HS may resolve and/or reduce the severity of the LAR. Although the PD20of the IAR is not changed, the severity of the IAR is also reduced after 1 yr
机译:摘要在这项研究中,我们想检验脱敏 (HS) 消除晚期哮喘反应 (LAR) 的假设。因此,我们选择了 15 名对室内尘螨 (HDM) 敏感的哮喘儿童(受试者),这通过阳性点刺试验和/或通过 RAST 的特异性 IgE 证明了这一点。所有患儿对 HDM 的支气管激发试验 (BPT) 均呈阳性;14 例显示双重哮喘反应,1 例显示孤立性 LAR。所有患儿均接受抗哮喘药物治疗,并接受HS治疗。他们在 HS 1 年后再次接受挑战,而他们的抗哮喘药物没有改变,除了仅用于缓解症状的β激动剂。在未接受 HS 的 8 名哮喘儿童(对照组)中也进行了两次 BPT,平均间隔为 6.4 个月。在对照组中,在两次BPT期间都观察到相同的反应模式。在受试者中,HS 1 年后 LAR 在 5/15 内完全消退 (P= 0.04)。此外,作为一个群体,受试者在 HS 1 年后表现出不太严重的 LAR(表示为 FEV1 的平均下降)(P<0.0001)。速发性哮喘反应(IAR)的PD20与HS开始前相同,但HS1年后IAR也较轻(表示为FEV1的平均下降)(P=0.028)。从这些观察结果中可以得出结论,在哮喘儿童中,HS 可能会解决和/或减轻 LAR 的严重程度。虽然IAR的PD20没有变化,但IAR的严重程度在1年后也会降低

著录项

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号